Diabetic Peripheral Neuropathy Market Size
Market Size in USD Bn
CAGR9.9%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 9.9% |
| Market Concentration | High |
| Major Players | Helixmith, Aptinyx, WinSanTor, Inc., Regenacy Pharmaceuticals, Grünenthal GmbH and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Diabetic Peripheral Neuropathy Market Analysis
The diabetic peripheral neuropathy market is estimated to be valued at USD 5.10 Bn in 2025 and is expected to reach USD 9.88 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032. The market is primarily driven by the rising global prevalence of diabetes and growing geriatric population worldwide who are at a higher risk of developing diabetic peripheral neuropathy (DPN).